Percentages of hEoP in normal and eosinophilia bone marrow
| Patient no. | Diagnosis | Age/sex | WBC (/µl) | Eosinophils in PB (%) | Eosinophils in BM (%) | hEoP in BMMNCs (%) | hEoP in Lin−CD34+ (%) |
| 1 | HES | 17/M | 18,510 | 12,957 (70) | NA | 0.227 | 7.72 |
| 2 | HES | 50/M | 29,530 | 14,647 (49.6) | NA | 0.253 | 6.87 |
| 3 | HES | 51/M | 13,220 | 4,680 (35.4) | 21.2 | 0.186 | 3.85 |
| 4 | HES | 62/F | 16,800 | 9,593 (57.1) | 36.4 | 0.047 | 12.7 |
| 5 | HES | 68/M | 12,800 | 3,430 (26.8) | 32.8 | 0.048 | 4.73 |
| 6 | T cell lymphoma | 75/F | 30,180 | 27,011 (89.5) | 66.8 | 0.039 | 11.8 |
| 7 | ATL | 60/M | 57,510 | 24,442 (42.5) | 38 | 0.056 | 5.66 |
| 8 | CML | 48/M | 436,000 | 34,008 (7.8) | 9.6 | 0.33 | 8.46 |
| 9 | AGA | 34/F | 23,210 | 14,669 (63.2) | 49.6 | 0.074 | 5.82 |
| 10 | AGA | 66/F | 40,000 | 33,240 (83.1) | 76.4 | 0.072 | 9.91 |
| 11 | unknown | 81/F | 9,300 | 2,632 (28.3) | 36.4 | 0.043 | 7.56 |
| 12 | unknown | 26/F | 10,970 | 5,331 (48.6) | 22.4 | 0.052 | 3.84 |
| 13 | unknown | 50/F | 13,610 | 3,062 (22.5) | 28.8 | 0.076 | 8.67 |
| 14 | unknown | 57/M | 21,020 | 13,747 (65.4) | 37.6 | 0.207 | 6.92 |
| 15 | unknown | 76/M | 10,380 | 3,529 (34) | 43.2 | 0.161 | 7.09 |
| Average | 57 | 49,536 | 13,799 (48.3) | 38.4 | 0.125 | 7.44 | |
| SD | (17–81) | 107,711 | 11,026 (23.2) | 18.1 | 0.094 | 2.61 | |
| Normal BM (n = 7) | |||||||
| Average | 46 | 5,164 | 176 (3.26) | 3.09 | 0.033 | 2.38 | |
| SD | (28–72) | 1,652 | 110 (1.21) | 1.17 | 0.013 | 0.46 |
| Patient no. | Diagnosis | Age/sex | WBC (/µl) | Eosinophils in PB (%) | Eosinophils in BM (%) | hEoP in BMMNCs (%) | hEoP in Lin−CD34+ (%) |
| 1 | HES | 17/M | 18,510 | 12,957 (70) | NA | 0.227 | 7.72 |
| 2 | HES | 50/M | 29,530 | 14,647 (49.6) | NA | 0.253 | 6.87 |
| 3 | HES | 51/M | 13,220 | 4,680 (35.4) | 21.2 | 0.186 | 3.85 |
| 4 | HES | 62/F | 16,800 | 9,593 (57.1) | 36.4 | 0.047 | 12.7 |
| 5 | HES | 68/M | 12,800 | 3,430 (26.8) | 32.8 | 0.048 | 4.73 |
| 6 | T cell lymphoma | 75/F | 30,180 | 27,011 (89.5) | 66.8 | 0.039 | 11.8 |
| 7 | ATL | 60/M | 57,510 | 24,442 (42.5) | 38 | 0.056 | 5.66 |
| 8 | CML | 48/M | 436,000 | 34,008 (7.8) | 9.6 | 0.33 | 8.46 |
| 9 | AGA | 34/F | 23,210 | 14,669 (63.2) | 49.6 | 0.074 | 5.82 |
| 10 | AGA | 66/F | 40,000 | 33,240 (83.1) | 76.4 | 0.072 | 9.91 |
| 11 | unknown | 81/F | 9,300 | 2,632 (28.3) | 36.4 | 0.043 | 7.56 |
| 12 | unknown | 26/F | 10,970 | 5,331 (48.6) | 22.4 | 0.052 | 3.84 |
| 13 | unknown | 50/F | 13,610 | 3,062 (22.5) | 28.8 | 0.076 | 8.67 |
| 14 | unknown | 57/M | 21,020 | 13,747 (65.4) | 37.6 | 0.207 | 6.92 |
| 15 | unknown | 76/M | 10,380 | 3,529 (34) | 43.2 | 0.161 | 7.09 |
| Average | 57 | 49,536 | 13,799 (48.3) | 38.4 | 0.125 | 7.44 | |
| SD | (17–81) | 107,711 | 11,026 (23.2) | 18.1 | 0.094 | 2.61 | |
| Normal BM (n = 7) | |||||||
| Average | 46 | 5,164 | 176 (3.26) | 3.09 | 0.033 | 2.38 | |
| SD | (28–72) | 1,652 | 110 (1.21) | 1.17 | 0.013 | 0.46 |
AGA, allergic granulomatous angitis; ATL, adult T cell leukemia; BMMNC, bone marrow MNC; CML, chronic myelogenous leukemia; NA, not applicable; PB, peripheral blood.